Jerel Davis
Individual
Managing Director at Versant Ventures focused on biotech. Launched 25+ portfolio companies including CRISPR Therapeutics (NASDAQ: CRSP). Former McKinsey Associate Principal.
Early Stage
Biotech
Healthcare
- Headquarters
- Vancouver, Canada
- Founded
- 1999
- Website
- versantventures.com
- AUM
- $2.4B
- Last Investment
- Nov 2025
- Geographic Focus
- Canada, United States
Investment Thesis
We invest in the healthcare sector, providing early and later-stage capital.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account